ClinVar Miner

Submissions for variant NM_017882.3(CLN6):c.662A>G (p.Tyr221Cys)

dbSNP: rs764571295
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV001004876 SCV001164358 uncertain significance Ceroid lipofuscinosis, neuronal, 6A 2018-12-03 criteria provided, single submitter research The homozygous p.Tyr221Cys variant in CLN6 was identified by our study in one individual with neuronal ceroid lipofuscinosis. The p.Tyr221Cys variant in CLN6 has been reported in 3 Sardinian individuals and 1 Turkish individual with neuronal ceroid lipofuscinosis and segregated with disease in 2 affected relatives from 1 family (PMID: 19135028, 19201763), but has been identified in 0.009746% (3/30782) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs764571295). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. This missense variant affects the same residue as a variant, p.Tyr221Cys, reported in association with neuronal ceroid lipofuscinosis in 1 Argentinian individual and 1 Turkish Individual with neuronal ceroid lipofuscinosis, slightly supporting that a change at this residue may not be tolerated (PMID: 12815591, 21990111). In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2, PP3, PM5_Supporting (Richards 2015).
Invitae RCV002549262 SCV003442996 uncertain significance Neuronal ceroid lipofuscinosis 2022-06-20 criteria provided, single submitter clinical testing This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 221 of the CLN6 protein (p.Tyr221Cys). This variant is present in population databases (rs764571295, gnomAD 0.01%). This missense change has been observed in individuals with variant late-infantile neuronal ceroid lipofuscinosis (v-LINCL) (PMID: 19135028). ClinVar contains an entry for this variant (Variation ID: 813907). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.